Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

SELL
$242.49 - $301.46 $4,849 - $6,029
-20 Reduced 1.54%
1,279 $314,000
Q2 2022

Jul 13, 2022

BUY
$224.73 - $338.64 $46,743 - $70,437
208 Added 19.07%
1,299 $322,000
Q1 2022

Apr 13, 2022

SELL
$277.25 - $366.29 $16,635 - $21,977
-60 Reduced 5.21%
1,091 $361,000
Q4 2021

Feb 10, 2022

BUY
$300.63 - $371.35 $124,460 - $153,738
414 Added 56.17%
1,151 $413,000
Q2 2021

Jul 26, 2021

BUY
$262.71 - $351.17 $6,042 - $8,076
23 Added 3.22%
737 $230,000
Q1 2021

May 03, 2021

BUY
$285.92 - $355.13 $17,155 - $21,307
60 Added 9.17%
714 $228,000
Q4 2020

Feb 08, 2021

BUY
$251.88 - $324.2 $16,120 - $20,748
64 Added 10.85%
654 $212,000
Q3 2020

Oct 13, 2020

SELL
$255.22 - $317.0 $8,167 - $10,144
-32 Reduced 5.14%
590 $163,000
Q2 2020

Jul 31, 2020

SELL
$141.4 - $257.09 $61,226 - $111,319
-433 Reduced 41.04%
622 $150,000
Q1 2020

May 12, 2020

SELL
$130.51 - $196.01 $27,146 - $40,770
-208 Reduced 16.47%
1,055 $153,000
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $104,666 - $146,865
-657 Reduced 34.22%
1,263 $215,000
Q3 2019

Oct 22, 2019

BUY
$175.89 - $279.23 $22,513 - $35,741
128 Added 7.14%
1,920 $341,000
Q2 2019

Jul 22, 2019

SELL
$250.96 - $284.94 $34,632 - $39,321
-138 Reduced 7.15%
1,792 $466,000
Q1 2019

Apr 15, 2019

BUY
$276.39 - $362.25 $43,393 - $56,873
157 Added 8.86%
1,930 $551,000
Q4 2018

Jan 28, 2019

SELL
$281.08 - $444.25 $96,129 - $151,933
-342 Reduced 16.17%
1,773 $576,000
Q3 2018

Nov 05, 2018

BUY
$354.53 - $449.75 $88,632 - $112,437
250 Added 13.4%
2,115 $940,000
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $171,847 - $275,757
618 Added 49.56%
1,865 $762,000
Q1 2018

Apr 24, 2018

BUY
$192.49 - $295.85 $13,859 - $21,301
72 Added 6.13%
1,247 $350,000
Q4 2017

Jan 24, 2018

BUY
$168.78 - $199.74 $198,316 - $234,694
1,175
1,175 $242,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.